Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Exchange Rate Effect: 2014-2024

Historic Exchange Rate Effect for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Dec 2024 value amounting to -$190,000.

  • Amphastar Pharmaceuticals' Exchange Rate Effect rose 34.92% to -$41,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $208,000, marking a year-over-year increase of 149.88%. This contributed to the annual value of -$190,000 for FY2024, which is 32.62% up from last year.
  • As of FY2024, Amphastar Pharmaceuticals' Exchange Rate Effect stood at -$190,000, which was up 32.62% from -$282,000 recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Exchange Rate Effect registered a high of $352,000 during FY2020, and its lowest value of -$282,000 during FY2023.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Exchange Rate Effect value was -$220,000 (recorded in 2022), while the average stood at -$230,667.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first soared by 438.46% in 2020, then tumbled by 163.35% in 2021.
  • Amphastar Pharmaceuticals' Exchange Rate Effect (Yearly) stood at $352,000 in 2020, then crashed by 163.35% to -$223,000 in 2021, then grew by 1.35% to -$220,000 in 2022, then declined by 28.18% to -$282,000 in 2023, then spiked by 32.62% to -$190,000 in 2024.